A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 1199-1210

  Hünniger, Kerstin ^a   Bieber, Kristin ^a   Martin, Ronny ^a   Lehnert, Teresa ^a,b   Figge, Marc Thilo ^a,b   Löffler, Jürgen ^c   Guo, Ren Feng ^d   Riedemann, Niels C ^d,e   Kurzai, Oliver ^a,b,e  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d InflaRx GmbH   (Germany)

^e JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; CELL ACTIVITY; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; NEUTROPHIL; NEUTROPHIL GRANULE; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PROTEIN FUNCTION; RESPIRATORY BURST; ANTAGONISTS AND INHIBITORS; CANDIDIASIS; DRUG EFFECTS; FUNGUS; IMMUNOLOGY; METABOLISM; MYCOSIS; TIME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD11B; CANDIDA ALBICANS; CANDIDIASIS; COMPLEMENT C5A; FUNGI; HUMANS; MYCOSES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; RECEPTOR, ANAPHYLATOXIN C5A; TIME FACTORS;

EID: 84921506013     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401845     Document Type: Article

References (41)

1. Delaloye, J., and T. Calandra. 2014. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5: 161-169.
2. Shoham, S., and S. M. Levitz. 2005. The immune response to fungal infections. Br. J. Haematol. 129: 569-582.
3. Wozniok, I., A. Hornbach, C. Schmitt, M. Frosch, H. Einsele, B. Hube, J. Löffler, and O. Kurzai. 2008. Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils. Cell. Microbiol. 10: 807-820.
4. Fradin, C., P. De Groot, D. MacCallum, M. Schaller, F. Klis, F. C. Odds, and B. Hube. 2005. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 56: 397-415.
5. Hünniger, K., T. Lehnert, K. Bieber, R. Martin, M. T. Figge, and O. Kurzai. 2014. A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood. PLOS Comput. Biol. 10: e1003479.
6. Netea, M. G., G. D. Brown, B. J. Kullberg, and N. A. Gow. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 6: 67-78.
7. van Lookeren Campagne, M., C. Wiesmann, and E. J. Brown. 2007. Macrophage complement receptors and pathogen clearance. Cell. Microbiol. 9: 2095-2102.
8. Luo, S., C. Skerka, O. Kurzai, and P. F. Zipfel. 2013. Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans. Mol. Immunol. 56: 161-169.
9. Losse, J., E. Svobodová, A. Heyken, B. Hube, P. F. Zipfel, and M. Józsi. 2011. Role of pH-regulated antigen 1 of Candida albicans in the fungal recognition and antifungal response of human neutrophils. Mol. Immunol. 48: 2135-2143.
10. Losse, J., P. F. Zipfel, and M. Józsi. 2010. Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J. Immunol. 184: 912-921.
11. Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9: 34-46.
12. Thong, Y. H., and A. Ferrante. 1978. Alternative pathway of complement activation by Candida albicans. Aust. N. Z. J. Med. 8: 620-622.
13. Morelli, R., and L. T. Rosenberg. 1971. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J. Immunol. 107: 476-480.
14. Shin, H. S., R. Snyderman, E. Friedman, A. Mellors, and M. M. Mayer. 1968. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162: 361-363.
15. Goldstein, I. M., and G. Weissmann. 1974. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J. Immunol. 113: 1583-1588.
16. Sacks, T., C. F. Moldow, P. R. Craddock, T. K. Bowers, and H. S. Jacob. 1978. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J. Clin. Invest. 61: 1161-1167.
17. Gerard, C. 2003. Complement C5a in the sepsis syndrome - too much of a good thing? N. Engl. J. Med. 348: 167-169.
18. Nakae, H., S. Endo, K. Inada, T. Takakuwa, T. Kasai, and M. Yoshida. 1994. Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84: 189-195.
19. Ward, P. A. 2004. The dark side of C5a in sepsis. Nat. Rev. Immunol. 4: 133-142.
20. Czermak, B. J., V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-Lang, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Protective effects of C5a blockade in sepsis. Nat. Med. 5: 788-792.
21. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. A key role of C5a/C5aR activation for the development of sepsis. J. Leukoc. Biol. 74: 966-970.
22. Cheng, S. C., T. Sprong, L. A. Joosten, J. W. van der Meer, B. J. Kullberg, B. Hube, L. Schejbel, P. Garred, M. van Deuren, and M. G. Netea. 2012. Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. Eur. J. Immunol. 42: 993-1004.
23. Mollnes, T. E., O. L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K. T. Lappegård, J. Köhl, and J. D. Lambris. 2002. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100: 1869-1877.
24. Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198: 179-182.
25. Radsak, M., C. Iking-Konert, S. Stegmaier, K. Andrassy, and G. M. Hänsch. 2000. Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation. Immunology 101: 521-530.
26. Huber-Lang, M. S., N. C. Riedeman, J. V. Sarma, E. M. Younkin, S. R. McGuire, I. J. Laudes, K. T. Lu, R. F. Guo, T. A. Neff, V. A. Padgaonkar, et al. 2002. Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 16: 1567-1574.
27. Forsyth, C. B., E. F. Plow, and L. Zhang. 1998. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J. Immunol. 161: 6198-6205.
28. Brekke, O. L., D. Christiansen, H. Fure, M. Fung, and T. E. Mollnes. 2007. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J. Leukoc. Biol. 81: 1404-1413.
29. Hellerud, B. C., J. Stenvik, T. Espevik, J. D. Lambris, T. E. Mollnes, and P. Brandtzaeg. 2008. Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation. Infect. Immun. 76: 4183-4189.
30. Skjeflo, E. W., D. Christiansen, T. Espevik, E. W. Nielsen, and T. E. Mollnes. 2014. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model. J. Immunol. 192: 2857-2864.
31. Abdel-Latif, D., M. Steward, D. L. Macdonald, G. A. Francis, M. C. Dinauer, and P. Lacy. 2004. Rac2 is critical for neutrophil primary granule exocytosis. Blood 104: 832-839.
32. Lacy, P. 2006. Mechanisms of degranulation in neutrophils. Allergy Asthma Clin. Immunol. 2: 98-108.
33. Lacy, P., and G. Eitzen. 2008. Control of granule exocytosis in neutrophils. Front. Biosci. 13: 5559-5570.
34. Wang, L., G. Han, R. Wang, G. Chen, R. Xu, H. Xiao, X. Li, S. Geng, Y. Li, X. Li, et al. 2010. Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis. Clin. Immunol. 137: 157-165.
35. van den Berg, C. W., D. V. Tambourgi, H. W. Clark, S. J. Hoong, O. B. Spiller, and E. P. McGreal. 2014. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor. J. Immunol. 192: 1787-1795.
36. Van Epps, D. E., S. Simpson, J. G. Bender, and D. E. Chenoweth. 1990. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J. Immunol. 144: 1062-1068.
37. Horn, F., T. Heinekamp, O. Kniemeyer, J. Pollmächer, V. Valiante, and A. A. Brakhage. 2012. Systems biology of fungal infection. Front Microbiol 3: 108.
38. Mech, F., D. Wilson, T. Lehnert, B. Hube, and M. Thilo Figge. 2014. Epithelial invasion outcompetes hypha development during Candida albicans infection as revealed by an image-based systems biology approach. Cytometry A 85: 126-139.
39. Guo, R. F., N. C. Riedemann, K. D. Bernacki, V. J. Sarma, I. J. Laudes, J. S. Reuben, E. M. Younkin, T. A. Neff, J. D. Paulauskis, F. S. Zetoune, and P. A. Ward. 2003. Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J. 17: 1889-1891.
40. Ward, P. A. 2010. The harmful role of c5a on innate immunity in sepsis. J. Innate Immun. 2: 439-445.
41. Unnewehr, H., D. Rittirsch, J. V. Sarma, F. Zetoune, M. A. Flierl, M. Perl, S. Denk, M. Weiss, M. E. Schneider, P. N. Monk, et al. 2013. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J. Immunol. 190: 4215-4225.